Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells

Aide Negria Department of Medicine and Surgery, University of Parma, Parma, Italy

Marina Marozzia Department of Medicine and Surgery, University of Parma, Parma, Italy

Daniela Trisciuogliob Institute of Molecular Biology and Pathology (IMBP), National Research Council (CNR) c/o Department of Biology and Biotechnology “Charles Darwin,” Sapienza University of Rome, Rome, Italy

Dante Rotilic Department of Chemistry and Technology of Drugs, Sapienza University of Rome, Rome, Italy

https://orcid.org/0000-0002-8428-8763

Antonello Maic Department of Chemistry and Technology of Drugs, Sapienza University of Rome, Rome, Italy

https://orcid.org/0000-0001-9176-2382

Federica Rizzia Department of Medicine and Surgery, University of Parma, Parma, Italy;d National Institute of Biostructure and Biosystems (INBB), Rome, ItalyCorrespondence[email protected]

Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date